MedPath

Clindamycin Phosphate

Clindamycin Phosphate Gel USP, 1% For External Use

Approved
Approval ID

b46941a9-e75f-48f7-b426-03f307499713

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 11, 2023

Manufacturers
FDA

Solaris Pharma Corporation

DUNS: 079904672

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clindamycin phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73473-300
Application NumberANDA211872
Product Classification
M
Marketing Category
C73584
G
Generic Name
clindamycin phosphate
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 11, 2023
FDA Product Classification

INGREDIENTS (1)

CLINDAMYCIN PHOSPHATEActive
Quantity: 10 mg in 1 g
Code: EH6D7113I8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clindamycin Phosphate - FDA Drug Approval Details